Brain Cancer Clinical Trials in Colorado

Showing 101-120 of 186 trials

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

NCT02386826

The purpose of this study is to determine whether the combination of two agents, INC280 and bevacizumab, is safe and effective when administered to patients with Glioblastoma Multiforme (GBM) who have progressed after receiving prior therapy or who have unresectable GBM.

Glioblastoma MultiformeGliosarcomaColorectal Cancer+1 more

SCRI Development Innovations, LLC65 participantsStarted Sep 2015

Denver, Colorado, United States • New Haven, Connecticut, United States • Kansas City, Missouri, United States +2 more locations

COMPLETEDPhase 153 miles

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT02780804

This phase I trial studies the side effects and best dose of entinostat in treating pediatric patients with solid tumors that have come back or have not responded to treatment. Entinostat may block some of the enzymes needed for cell division and it may help to kill tumor cells.

Brain Stem NeoplasmPineal Region NeoplasmRecurrent Lymphoma+7 more

National Cancer Institute (NCI)21 participantsStarted Jan 2017

Birmingham, Alabama, United States • Los Angeles, California, United States • Orange, California, United States +18 more locations

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Brain Cancer Trials in Other Cities

Expanded Access Protocol Using 131I-MIBG

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

Metformin in Children With Relapsed or Refractory Solid Tumors

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

3D Prediction of Patient-Specific Response

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban

Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma

A Study in Subjects With Recurrent Malignant Glioma

Other Conditions in Colorado